Integrative Transcriptomic Analysis Identify Potential m6A Pathway-Related Drugs That Inhibit Cancer Cell Proliferation.
Jing-Kun YiRucong LiuYu LiuTing GuoYang LiYuan ZhouPublished in: Genes (2022)
Recent studies have found that m6A modification of mRNA may play important roles in the progression of various types of cancers. However, current knowledge about drugs that can interfere with m6A methylation and inhibit cancer cell proliferation is still far from comprehensive. To this end, we performed integrative analysis on transcriptome data with perturbation of m6A writers or erasers and identified consensus m6A-related differentially expressed genes (DEGs). Comparative analysis of these m6A-related DEGs with Connectivity Map signatures highlight potential m6A-targeted drugs. Among them, we experimentally verified the inhibitory effects of AZ628 on the proliferation of human breast cancer cell lines and R428 on the proliferation of human melanoma cell lines. Both drugs can significantly reduce the cellular level of m6A modification. These results suggest an m6A-related new target pathway by AZ628 and R428 and provide new candidate m6A-related drugs that inhibit cancer cell proliferation.
Keyphrases
- cell proliferation
- papillary thyroid
- genome wide
- squamous cell
- drug induced
- squamous cell carcinoma
- multiple sclerosis
- risk assessment
- machine learning
- dna methylation
- single cell
- lymph node metastasis
- childhood cancer
- climate change
- binding protein
- young adults
- clinical practice
- cancer therapy
- functional connectivity
- deep learning
- network analysis
- skin cancer
- pluripotent stem cells
- bioinformatics analysis